GSK (NYSE: GSK) sets total voting rights at 4.06B shares
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
GSK plc reported its total voting rights as of 31 March 2026. The company had 4,316,179,781 issued ordinary shares of 31 ¼ pence each, with 256,112,615 shares held in treasury. This leaves 4,060,067,166 voting rights, which shareholders can use as the denominator for disclosure threshold calculations under UK transparency rules.
Positive
- None.
Negative
- None.
Key Figures
Issued share capital: 4,316,179,781 ordinary shares
Treasury shares: 256,112,615 ordinary shares
Total voting rights: 4,060,067,166
+1 more
4 metrics
Issued share capital
4,316,179,781 ordinary shares
Issued share capital as at 31 March 2026
Treasury shares
256,112,615 ordinary shares
Held in treasury as at 31 March 2026
Total voting rights
4,060,067,166
Shares with voting rights as at 31 March 2026
Nominal value per share
31 ¼ pence per share
Ordinary shares nominal value
Key Terms
Total Voting Rights, Treasury, Disclosure Guidance and Transparency Rule 5.6.1R, voting rights, +1 more
5 terms
Total Voting Rights financial
"Total Voting Rights In conformity with the Financial Conduct Authority's Disclosure Guidance"
The total voting rights number is the count of shares that carry the right to vote at a company’s shareholder meetings, reflecting how much voting power exists in the market. Investors use it to understand control and influence—like knowing how many votes are in play when measuring ownership stakes, calculating a shareholder’s voting percentage, or assessing how easy it would be for a holder to sway decisions.
Treasury financial
"of which 256,112,615 Ordinary Shares were held in Treasury."
The treasury is the department or area within a government or organization responsible for managing its money, finances, and financial strategies. It handles tasks like collecting revenue, paying bills, and planning for future financial needs, much like a household manages its budget. For investors, understanding the treasury is important because it influences interest rates, government spending, and overall economic stability.
Disclosure Guidance and Transparency Rule 5.6.1R regulatory
"In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R"
voting rights financial
"Therefore, the total number of voting rights in the Company is 4,060,067,166."
Voting rights are the ability of shareholders to have a say in important company decisions, like choosing leaders or approving big changes. They matter because they give owners a voice in how the company is run, similar to how voters influence elections, ensuring the company acts in shareholders’ interests.
Financial Conduct Authority regulatory
"In conformity with the Financial Conduct Authority's Disclosure Guidance"
A government-authorized regulator that sets and enforces rules for banks, brokers, insurers and other financial firms to keep markets fair and safe. Think of it as a referee for the financial system: it watches for cheating, protects consumers, and can penalize companies that break the rules. Its actions matter to investors because enforcement decisions, rule changes or approvals influence company costs, reputations and overall market confidence.
FAQ
What total voting rights did GSK (GSK) report as of 31 March 2026?
GSK reported a total of 4,060,067,166 voting rights as of 31 March 2026. Shareholders can use this figure as the denominator when assessing whether they must notify holdings under the UK Disclosure Guidance and Transparency Rules.
Why is GSK (GSK) publishing a total voting rights figure?
GSK publishes its total voting rights to comply with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rule 5.6.1R. This helps investors determine when their shareholding crosses regulatory thresholds that require notification of interests or changes in interests.